Two Sigma Advisers’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-55,838
| Closed | -$37K | – | 2961 |
|
|
2022
Q1 | $37K | Sell |
55,838
-15,400
| -22% | -$10.2K | ﹤0.01% | 2623 |
|
|
2021
Q4 | $92K | Sell |
71,238
-17,563
| -20% | -$22.7K | ﹤0.01% | 2419 |
|
|
2021
Q3 | $193K | Sell |
88,801
-213,300
| -71% | -$464K | ﹤0.01% | 2257 |
|
|
2021
Q2 | $825K | Sell |
302,101
-21,300
| -7% | -$58.2K | ﹤0.01% | 1718 |
|
|
2021
Q1 | $844K | Buy |
+323,401
| New | +$844K | ﹤0.01% | 1742 |
|
|
2020
Q4 | – | Sell |
-86,377
| Closed | -$399K | – | 2651 |
|
|
2020
Q3 | $399K | Buy |
+86,377
| New | +$399K | ﹤0.01% | 1904 |
|
|
2018
Q2 | – | Sell |
-6,063
| Closed | -$65K | – | 2535 |
|
|
2018
Q1 | $65K | Buy |
+6,063
| New | +$65K | ﹤0.01% | 2249 |
|
|
2017
Q4 | – | Sell |
-1,588
| Closed | -$87K | – | 2418 |
|
|
2017
Q3 | $87K | Buy |
1,588
+288
| +22% | +$15.8K | ﹤0.01% | 2130 |
|
|
2017
Q2 | $241K | Buy |
+1,300
| New | +$241K | ﹤0.01% | 2062 |
|